These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20681478)

  • 1. Discovering breast cancer drug candidates from biomedical literature.
    Li J; Zhu X; Chen JY
    Int J Data Min Bioinform; 2010; 4(3):241-55. PubMed ID: 20681478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SemaTyP: a knowledge graph based literature mining method for drug discovery.
    Sang S; Yang Z; Wang L; Liu X; Lin H; Wang J
    BMC Bioinformatics; 2018 May; 19(1):193. PubMed ID: 29843590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C²Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships.
    Huang H; Wu X; Pandey R; Li J; Zhao G; Ibrahim S; Chen JY
    BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S17. PubMed ID: 23134618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up).
    Icli F; Akbulut H; Onur H; Yalcin B; Demirkazık A; Senler FÇ
    Breast; 2011 Apr; 20(2):155-7. PubMed ID: 20951586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does paclitaxel improve local control in breast cancer?
    Bonn D
    Lancet Oncol; 2005 Feb; 6(2):72. PubMed ID: 15704297
    [No Abstract]   [Full Text] [Related]  

  • 7. Mining emerging biomedical literature for understanding disease associations in drug discovery.
    Rajpal DK; Qu XA; Freudenberg JM; Kumar VD
    Methods Mol Biol; 2014; 1159():171-206. PubMed ID: 24788268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
    Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
    Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
    Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerations.
    Perez EA
    Cancer Invest; 2001; 19(2):155-64. PubMed ID: 11296620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
    Formenti SC; Volm M; Skinner KA; Spicer D; Cohen D; Perez E; Bettini AC; Groshen S; Gee C; Florentine B; Press M; Danenberg P; Muggia F
    J Clin Oncol; 2003 Mar; 21(5):864-70. PubMed ID: 12610186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer.
    Panday VR; ten Bokkel Huinink WW; Rosing H; Koopman FJ; Hillebrand MJ; Dubbelman RC; van Tellingen O; Schellens JH; Beijnen JH
    Anticancer Drugs; 1998 Sep; 9(8):665-73. PubMed ID: 9823424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.
    Wang L; Ingle J; Weinshilboum R
    Clin Pharmacol Ther; 2018 Feb; 103(2):243-252. PubMed ID: 29052219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel in doxorubicin-resistant metastatic breast cancer patients.
    Anand A; Anand A
    J Natl Cancer Inst; 1995 Nov; 87(21):1642. PubMed ID: 7563210
    [No Abstract]   [Full Text] [Related]  

  • 16. DGIdb: mining the druggable genome.
    Griffith M; Griffith OL; Coffman AC; Weible JV; McMichael JF; Spies NC; Koval J; Das I; Callaway MB; Eldred JM; Miller CA; Subramanian J; Govindan R; Kumar RD; Bose R; Ding L; Walker JR; Larson DE; Dooling DJ; Smith SM; Ley TJ; Mardis ER; Wilson RK
    Nat Methods; 2013 Dec; 10(12):1209-10. PubMed ID: 24122041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
    Sudha T; Bharali DJ; Yalcin M; Darwish NH; Debreli Coskun M; Keating KA; Lin HY; Davis PJ; Mousa SA
    Int J Nanomedicine; 2017; 12():1305-1315. PubMed ID: 28243091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Text Mining for Drug Discovery.
    Zheng S; Dharssi S; Wu M; Li J; Lu Z
    Methods Mol Biol; 2019; 1939():231-252. PubMed ID: 30848465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel plus doxorubicin in metastatic breast Ca: the Milan experience.
    Gianni L
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):13-5. PubMed ID: 9516596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    Mitsopoulos C; Di Micco P; Fernandez EV; Dolciami D; Holt E; Mica IL; Coker EA; Tym JE; Campbell J; Che KH; Ozer B; Kannas C; Antolin AA; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2021 Jan; 49(D1):D1074-D1082. PubMed ID: 33219674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.